{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:04:38Z","timestamp":1790845478588,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-162365"],"award-info":[{"award-number":["PJT-162365"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The approval of plazomicin broadened the clinical library of aminoglycosides available for use against emerging bacterial pathogens. Contrarily to other aminoglycosides, resistance to plazomicin is limited; still, instances of resistance have been reported in clinical settings. Here, we present structural insights into the mechanism of plazomicin action and the mechanisms of clinical resistance. The structural data reveal that plazomicin exclusively binds to the 16S ribosomal A site, where it likely interferes with the fidelity of mRNA translation. The unique extensions to the core aminoglycoside scaffold incorporated into the structure of plazomicin do not interfere with ribosome binding, which is analogously seen in the binding of this antibiotic to the AAC(2\u2032)-Ia resistance enzyme. The data provides a structural rationale for resistance conferred by drug acetylation and ribosome methylation, i.e., the two mechanisms of resistance observed clinically. Finally, the crystal structures of plazomicin in complex with both its target and the clinically relevant resistance factor provide a roadmap for next-generation drug development that aims to ameliorate the impact of antibiotic resistance.<\/jats:p>","DOI":"10.1038\/s42003-021-02261-4","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T10:08:03Z","timestamp":1623406083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Structural basis for plazomicin antibiotic action and resistance"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6204-6739","authenticated-orcid":false,"given":"Tolou","family":"Golkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8266-4569","authenticated-orcid":false,"given":"Angelia V.","family":"Bassenden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnagopal","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5873-1066","authenticated-orcid":false,"given":"Dev P.","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8061-0436","authenticated-orcid":false,"given":"T. Martin","family":"Schmeing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2663-025X","authenticated-orcid":false,"given":"Albert M.","family":"Berghuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"2261_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nmni.2015.02.007","volume":"6","author":"I Roca","year":"2015","unstructured":"Roca, I. et al. The global threat of antimicrobial resistance: science for intervention. N. Microbes N. Infect. 6, 22\u201329 (2015).","journal-title":"N. Microbes N. Infect."},{"key":"2261_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli, E. et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318\u2013327 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"2261_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrmicro.2017.75","volume":"15","author":"MO Sommer","year":"2017","unstructured":"Sommer, M. O., Munck, C., Toft-Kehler, R. V. & Andersson, D. I. Prediction of antibiotic resistance: time for a new preclinical paradigm? Nat. Rev. Microbiol. 15, 689\u2013696 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"2261_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/35030019","volume":"407","author":"AP Carter","year":"2000","unstructured":"Carter, A. P. et al. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407, 340\u2013348 (2000).","journal-title":"Nature"},{"key":"2261_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/cr0301088","volume":"105","author":"S Magnet","year":"2005","unstructured":"Magnet, S. & Blanchard, J. S. Molecular insights into aminoglycoside action and resistance. Chem. Rev. 105, 477\u2013498 (2005).","journal-title":"Chem. Rev."},{"key":"2261_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40265-019-1054-3","volume":"79","author":"K Eljaaly","year":"2019","unstructured":"Eljaaly, K., Alharbi, A., Alshehri, S., Ortwine, J. K. & Pogue, J. M. Plazomicin: a novel aminoglycoside for the treatment of resistant Gram-negative bacterial infections. Drugs 79, 243\u2013269 (2019).","journal-title":"Drugs"},{"key":"2261_CR7","doi-asserted-by":"publisher","first-page":"e02068-18","DOI":"10.1128\/AAC.02068-18","volume":"63","author":"A Walkty","year":"2019","unstructured":"Walkty, A., Karlowsky, J. A., Baxter, M. R., Adam, H. J. & Zhanel, G. G. In vitro activity of plazomicin against gram-negative and gram-positive bacterial pathogens isolated from patients in Canadian hospitals from 2013 to 2017 as part of the CANWARD surveillance study. Antimicrob. Agents Chemother. 63,\u00a0e02068-18\u00a0(2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2261_CR8","first-page":"3346","volume":"73","author":"M Castanheira","year":"2018","unstructured":"Castanheira, M. et al. Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms. J. Antimicrob. Chemother. 73, 3346\u20133354 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"2261_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/jac\/dkq408","volume":"66","author":"D Livermore","year":"2011","unstructured":"Livermore, D. et al. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J. Antimicrob. Chemother. 66, 48\u201353 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"2261_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3801-1","volume":"19","author":"I Galani","year":"2019","unstructured":"Galani, I. et al. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance. BMC Infect. Dis. 19, 167 (2019).","journal-title":"BMC Infect. Dis."},{"key":"2261_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2018.10.023","volume":"94","author":"M Castanheira","year":"2019","unstructured":"Castanheira, M., Davis, A. P., Serio, A. W., Krause, K. M. & Mendes, R. E. In vitro activity of plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in US Census divisions. Diagn. Microbiol. Infect. Dis. 94, 73\u201377 (2019).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"2261_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/phar.2203","volume":"39","author":"KM Shaeer","year":"2019","unstructured":"Shaeer, K. M., Zmarlicka, M. T., Chahine, E. B., Piccicacco, N. & Cho, J. C. Plazomicin: a next\u2010generation aminoglycoside. Pharmacotherapy 39, 77\u201393 (2019).","journal-title":"Pharmacotherapy"},{"key":"2261_CR13","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1021\/acsinfecdis.8b00001","volume":"4","author":"G Cox","year":"2018","unstructured":"Cox, G. et al. Plazomicin retains antibiotic activity against most aminoglycoside modifying enzymes. ACS Infect. Dis. 4, 980\u2013987 (2018).","journal-title":"ACS Infect. Dis."},{"key":"2261_CR14","first-page":"180","volume":"60","author":"Achaogen.","year":"2018","unstructured":"Achaogen. Plazomicin (Zemdri)\u2014a new aminoglycoside antibiotic. Med. Lett. Drugs Ther. 60, 180\u2013182 (2018).","journal-title":"Med. Lett. Drugs Ther."},{"key":"2261_CR15","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1128\/AAC.00572-10","volume":"54","author":"JB Aggen","year":"2010","unstructured":"Aggen, J. B. et al. Synthesis and spectrum of the neoglycoside ACHN-490. Antimicrob. Agents Chemother. 54, 4636\u20134642 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2261_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","volume":"49","author":"K Poole","year":"2005","unstructured":"Poole, K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49, 479\u2013487 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2261_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","volume":"13","author":"MS Ramirez","year":"2010","unstructured":"Ramirez, M. S. & Tolmasky, M. E. Aminoglycoside modifying enzymes. Drug Resist. Updates 13, 151\u2013171 (2010).","journal-title":"Drug Resist. Updates"},{"key":"2261_CR18","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1261\/rna.069260.118","volume":"25","author":"MS Svetlov","year":"2019","unstructured":"Svetlov, M. S. et al. High-resolution crystal structures of ribosome-bound chloramphenicol and erythromycin provide the ultimate basis for their competition. RNA 25, 600\u2013606 (2019).","journal-title":"RNA"},{"key":"2261_CR19","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1126\/science.1131127","volume":"313","author":"M Selmer","year":"2006","unstructured":"Selmer, M. et al. Structure of the 70S ribosome complexed with mRNA and tRNA. Science 313, 1935\u20131942 (2006).","journal-title":"Science"},{"key":"2261_CR20","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1093\/nar\/gki862","volume":"33","author":"B Fran\u00e7ois","year":"2005","unstructured":"Fran\u00e7ois, B. et al. Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding. Nucleic Acids Res. 33, 5677\u20135690 (2005).","journal-title":"Nucleic Acids Res."},{"key":"2261_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nsmb1271","volume":"14","author":"MA Borovinskaya","year":"2007","unstructured":"Borovinskaya, M. A. et al. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling. Nat. Struct. Mol. Biol. 14, 727\u2013732 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2261_CR22","doi-asserted-by":"publisher","unstructured":"Bassenden, A. V. et al. Structural and phylogenetic analyses of resistance to next-generation aminoglycosides conferred by AAC(2\u2032) enzymes.\u00a0Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-021-89446-3 (in press, 2021).","DOI":"10.1038\/s41598-021-89446-3"},{"key":"2261_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1110\/ps.0233503","volume":"12","author":"DL Burk","year":"2003","unstructured":"Burk, D. L., Ghuman, N., Wybenga\u2010Groot, L. E. & Berghuis, A. M. X\u2010ray structure of the AAC (6\u2032)\u2010Ii antibiotic resistance enzyme at 1.8 \u00c5 resolution; examination of oligomeric arrangements in GNAT superfamily members. Protein Sci. 12, 426\u2013437 (2003).","journal-title":"Protein Sci."},{"key":"2261_CR24","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1093\/emboj\/21.10.2323","volume":"21","author":"DH Fong","year":"2002","unstructured":"Fong, D. H. & Berghuis, A. M. Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry. EMBO J. 21, 2323\u20132331 (2002).","journal-title":"EMBO J."},{"key":"2261_CR25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1021\/acschembio.5b01070","volume":"11","author":"AV Bassenden","year":"2016","unstructured":"Bassenden, A. V., Rodionov, D., Shi, K. & Berghuis, A. M. Structural analysis of the tobramycin and gentamicin clinical resistome reveals limitations for next-generation aminoglycoside design. ACS Chem. Biol. 11, 1339\u20131346 (2016).","journal-title":"ACS Chem. Biol."},{"key":"2261_CR26","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.biochi.2006.05.018","volume":"88","author":"A Lescoute","year":"2006","unstructured":"Lescoute, A. & Westhof, E. The A-minor motifs in the decoding recognition process. Biochimie 88, 993\u2013999 (2006).","journal-title":"Biochimie"},{"key":"2261_CR27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nrm2352","volume":"9","author":"TA Steitz","year":"2008","unstructured":"Steitz, T. A. A structural understanding of the dynamic ribosome machine. Nat. Rev. Mol. Cell Biol. 9, 242\u2013253 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2261_CR28","doi-asserted-by":"publisher","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","volume":"6","author":"KM Krause","year":"2016","unstructured":"Krause, K. M., Serio, A. W., Kane, T. R. & Connolly, L. E. Aminoglycosides: an overview. Cold Spring Harb. Perspect. Med. 6, a027029 (2016).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2261_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1039\/C5MD00384A","volume":"7","author":"VR Bacot-Davis","year":"2016","unstructured":"Bacot-Davis, V. R., Bassenden, A. V. & Berghuis, A. M. Drug-target networks in aminoglycoside resistance: hierarchy of priority in structural drug design. MedChemComm 7, 103\u2013113 (2016).","journal-title":"MedChemComm"},{"key":"2261_CR30","doi-asserted-by":"publisher","first-page":"e00202-18","DOI":"10.1128\/AAC.00202-18","volume":"62","author":"SJ Caldwell","year":"2018","unstructured":"Caldwell, S. J. & Berghuis, A. M. Plasticity of aminoglycoside binding to antibiotic kinase APH (2\u2033)-Ia. Antimicrob. Agents Chemother. 62,\u00a0e00202-18 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2261_CR31","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/jac\/dky546","volume":"74","author":"M Juhas","year":"2019","unstructured":"Juhas, M. et al. In vitro activity of apramycin against multidrug-, carbapenem-and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii. J. Antimicrob. Chemother. 74, 944\u2013952 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"2261_CR32","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1021\/acsinfecdis.9b00128","volume":"5","author":"GC Sati","year":"2019","unstructured":"Sati, G. C. et al. Modification at the 2\u2032-position of the 4, 5-series of 2-deoxystreptamine aminoglycoside antibiotics to resist aminoglycoside modifying enzymes and increase ribosomal target selectivity. ACS Infect. Dis. 5, 1718\u20131730 (2019).","journal-title":"ACS Infect. Dis."},{"key":"2261_CR33","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1021\/acsinfecdis.8b00052","volume":"4","author":"A Sonousi","year":"2018","unstructured":"Sonousi, A. et al. Effects of the 1-N-(4-amino-2 S-hydroxybutyryl) and 6'-N-(2-hydroxyethyl) substituents on ribosomal selectivity, cochleotoxicity, and antibacterial activity in the sisomicin class of aminoglycoside antibiotics. ACS Infect. Dis. 4, 1114\u20131120 (2018).","journal-title":"ACS Infect. Dis."},{"key":"2261_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0022-2836(62)80015-1","volume":"4","author":"G Zubay","year":"1962","unstructured":"Zubay, G. The isolation and fractionation of soluble ribonucleic acid. J. Mol. Biol. 4, 347\u2013356 (1962).","journal-title":"J. Mol. Biol."},{"key":"2261_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0022-2836(92)91000-F","volume":"224","author":"J-M Guillon","year":"1992","unstructured":"Guillon, J.-M. et al. Nucleotides of tRNA governing the specificity of Escherichia coli methionyl-tRNAfMet formyltransferase. J. Mol. Biol. 224, 359\u2013367 (1992).","journal-title":"J. Mol. Biol."},{"key":"2261_CR36","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1093\/nar\/28.12.e64","volume":"28","author":"E Cayama","year":"2000","unstructured":"Cayama, E. et al. New chromatographic and biochemical strategies for quick preparative isolation of tRNA. Nucleic Acids Res. 28, e64\u2013e64 (2000).","journal-title":"Nucleic Acids Res."},{"key":"2261_CR37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/nar\/24.5.907","volume":"24","author":"R J\u00fcnemann","year":"1996","unstructured":"J\u00fcnemann, R. et al. In vivo deuteration of transfer RNAs: overexpression and large-scale purification of deuterated specific tRNAs. Nucleic Acids Res. 24, 907\u2013913 (1996).","journal-title":"Nucleic Acids Res."},{"key":"2261_CR38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.molcel.2014.09.020","volume":"56","author":"YS Polikanov","year":"2014","unstructured":"Polikanov, Y. S. et al. Amicoumacin A inhibits translation by stabilizing mRNA interaction with the ribosome. Mol. Cell 56, 531\u2013540 (2014).","journal-title":"Mol. Cell"},{"key":"2261_CR39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.molcel.2014.09.021","volume":"56","author":"YS Polikanov","year":"2014","unstructured":"Polikanov, Y. S. et al. Negamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA. Mol. Cell 56, 541\u2013550 (2014).","journal-title":"Mol. Cell"},{"key":"2261_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1107\/S0021889809045701","volume":"43","author":"G Winter","year":"2010","unstructured":"Winter, G. xia2: an expert system for macromolecular crystallography data reduction. J. Appl. Crystallogr. 43, 186\u2013190 (2010).","journal-title":"J. Appl. Crystallogr."},{"key":"2261_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1107\/S2059798317017235","volume":"74","author":"G Winter","year":"2018","unstructured":"Winter, G. et al. DIALS: implementation and evaluation of a new integration package. Acta Crystallogr. Sect. D 74, 85\u201397 (2018).","journal-title":"Acta Crystallogr. Sect. D"},{"key":"2261_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"2261_CR43","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"2261_CR44","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1107\/S0907444909029436","volume":"65","author":"NW Moriarty","year":"2009","unstructured":"Moriarty, N. W., Grosse-Kunstleve, R. W. & Adams, P. D. Electronic ligand builder and optimization workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. Sect. D Biol. Crystallogr. 65, 1074\u20131080 (2009).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"2261_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","volume":"41","author":"FW Studier","year":"2005","unstructured":"Studier, F. W. Protein production by auto-induction in high-density shaking cultures. Protein Expr. Purif. 41, 207\u2013234 (2005).","journal-title":"Protein Expr. Purif."},{"key":"2261_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-1-59745-246-5_20","volume":"142","author":"EH Serpersu","year":"2008","unstructured":"Serpersu, E. H., Ozen, C. & Wright, E. Studies of enzymes that cause resistance to aminoglycosides antibiotics. Methods Mol. Med. 142, 261\u2013271 (2008).","journal-title":"Methods Mol. Med."},{"key":"2261_CR47","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1107\/S0907444994003112","volume":"50","author":"N. Collaborative Computational Project.","year":"1994","unstructured":"N. Collaborative Computational Project. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760\u2013763 (1994).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2261_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1107\/S0907444905036693","volume":"62","author":"P Evans","year":"2006","unstructured":"Evans, P. Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr. 62, 72\u201382 (2006).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2261_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02261-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02261-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02261-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T19:31:21Z","timestamp":1670095881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02261-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2261"],"URL":"https:\/\/doi.org\/10.1038\/s42003-021-02261-4","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"28 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"729"}}